These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1017593)

  • 1. Serum glycoproteins in the liver diseases. II. Radioimmunoassay of alpha-1 acid glycoprotein.
    Arima T; Motoyama Y; Nagata K; Kondo T
    Gastroenterol Jpn; 1976; 11(4):307-12. PubMed ID: 1017593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum glycoproteins in the liver diseases. I. Studies on sialic acid-free glycoproteins-improved competitive binding assay of desialylated glycoprotein by rat liver plasma membrane.
    Arima T; Motoyama Y; Nagata K; Kondo T
    Gastroenterol Jpn; 1976; 11(4):300-6. PubMed ID: 1017592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum levels of a biliary glycoprotein (BGP I) in patients with liver or biliary tract disease.
    Svenberg T; Wahren B; Hammarström S
    Clin Exp Immunol; 1979 May; 36(2):317-25. PubMed ID: 477033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum glycoproteins in the liver diseases. IV. Alpha-1 acid glycoprotein level in liver cirrhosis.
    Arima T; Motoyama Y; Yamamoto T; Nagata K; Kondo T
    Gastroenterol Jpn; 1977; 12(2):43-6. PubMed ID: 892335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serum protein profile in chronic hepatitis, cirrhosis and liver cancer.
    Hiramatsu S; Kojima J; Okada TT; Inai S; Ohmori K
    Acta Hepatogastroenterol (Stuttg); 1976 Jun; 23(3):177-82. PubMed ID: 60035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum glycoprotein concentrations in chronic liver diseases].
    Fehér J; Jakab L; Szilvási I
    Orv Hetil; 1973; 114(29):1737-41. PubMed ID: 4721855
    [No Abstract]   [Full Text] [Related]  

  • 7. Sialic acid contents of glycoprotein and seromucoid in liver diseases.
    Kaniak J; Mejbaum-Katzenelenbogen W; Jelewska-Kaniakowa Z; Kudrewicz-Hubicka Z; Kowal-Gierczak B
    Pol Med J; 1970; 9(5):1076-81. PubMed ID: 5510277
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma metallothionein concentration in patients with liver disorders: special emphasis on the relation with primary biliary cirrhosis.
    Mulder TP; Janssens AR; Verspaget HW; Lamers CB
    Hepatology; 1991 Dec; 14(6):1008-12. PubMed ID: 1959846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoassay of "pregnancy-specific"-beta 1-glycoprotein (SP1).
    Kaminska J; Calvert I; Rosen SW
    Clin Chem; 1979 Apr; 25(4):577-80. PubMed ID: 89016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of serum alpha-fetoprotein determination. Experiences with our own radioimmunoassay].
    Lamerz R; Schmalhorst U; Grunst J; Fateh-Moghadam A; Eisenburg J
    Fortschr Med; 1976 Apr; 94(12):702-10. PubMed ID: 61154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in plasma vitronectin, fibronectin, and serum laminin P1 levels and immunohistochemical study of vitronectin in the liver of patients with chronic liver diseases].
    Tomihira M
    Fukuoka Igaku Zasshi; 1991 Jan; 82(1):21-30. PubMed ID: 1708742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal reaction and serum glycoprotein concentration in chronic hepatitis and liver cirrhosis.
    Fehér J; Jakab L; Józsa L; Szilvási I; Papp G
    Acta Morphol Acad Sci Hung; 1975; 23(4):319-26. PubMed ID: 1234831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific 125I-radioimmunoassay for cholyglycine, a bile acid, in serum.
    Miller P; Weiss S; Cornell M; Dockery J
    Clin Chem; 1981 Oct; 27(10):1698-703. PubMed ID: 7285320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of a radioimmunoassay procedure for the estimation of Tamm-Horsfall glycoprotein in human serum.
    Avis PJ
    Clin Sci Mol Med; 1977 Feb; 52(2):183-91. PubMed ID: 844251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence and significance of antibody to liver-specific membrane lipoprotein by double-antibody immunoprecipitation method in sera of patients with acute and chronic liver diseases.
    Kakumu S; Arakawa Y; Goji H; Kashio T; Yata K
    Gastroenterology; 1979 Apr; 76(4):665-72. PubMed ID: 105959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia.
    Wu JC; Daughaday WH; Lee SD; Hsiao TS; Chou CK; Lin HD; Tsai YT; Chiang BN
    J Lab Clin Med; 1988 Nov; 112(5):589-94. PubMed ID: 2460570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage.
    Marshall JS; Green AM; Pensky J; Williams S; Zinn A; Carlson DM
    J Clin Invest; 1974 Sep; 54(3):555-62. PubMed ID: 4137057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of serum acid soluble glycoproteins (ASP) and immunosuppressive acidic protein (IAP) in inflammatory diseases and liver diseases].
    Shibasaki K; Soga K; Toshima M; Aikawa K; Itoh T; Takahashi Y; Tsuchimochi M; Mataga I; Tsuchikawa K; Kato J
    Shigaku; 1989 Oct; 77(3):1031-41. PubMed ID: 2489330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A radioimmunoassay of primary bile acid conjugates in human serum.
    Roda A; Roda E; Festi D; Sama C; Mazzella G; Aldini R; Barbara L
    Ric Clin Lab; 1977; 7(2):163-78. PubMed ID: 562528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between serum sialic acid and sialylated glycoproteins in alcoholics.
    Chrostek L; Cylwik B; Krawiec A; Korcz W; Szmitkowski M
    Alcohol Alcohol; 2007; 42(6):588-92. PubMed ID: 17573378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.